Search

Author/Creator Levin, Mark‐David

1. Abdominal pain in combination with an unexplained hemolytic anemia are crucial signs to test for paroxysmal nocturnal hemoglobinuria: A case report. Issue 1 (4th December 2018)

Authors:
Elias, N.S.; Riedl, Jürgen; Stouten, Karlijn; Levin, Mark‐David; Wolfhagen, Frank; Eefting, Mathijs; Vermeer, Henricus Jan
Journal:
Clinical case reports
Issue:
Volume 7:Issue 1(2019)
Page Start:
175
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Blood cell counts and lymphocyte subsets of patients admitted during the COVID‐19 pandemic: a prospective cohort study. (28th July 2020)

Authors:
Hengeveld, Paul J.; Khader, Aaram O.; de Bruin, Linda H. A.; Geelen, Inge G. P.; van Baalen, Eske A.; Jansen, Eva; Bouwer, Nathalie I.; Balak, Ömer; Riedl, Jurgen A.; Langerak, Anton W.; Westerweel, Peter E.; Levin, Mark‐David
Journal:
British journal of haematology
Issue:
Volume 190:Number 4(2020)
Page Start:
e201
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. First‐Line Palliative HER2‐Targeted Therapy in HER2‐Positive Metastatic Breast Cancer Is Less Effective After Previous Adjuvant Trastuzumab‐Based Therapy. (22nd May 2017)

Authors:
Rier, Hánah N.; Levin, Mark‐David; van Rosmalen, Joost; Bos, Monique M. E. M.; Drooger, Jan C.; de Jong, Paul; Portielje, Johanneke E. A.; Elsten, Elisabeth M. P.; Ten Tije, Albert‐Jan; Sleijfer, Stefan; Jager, Agnes
Journal:
Oncologist
Issue:
Volume 22:Number 8(2017)
Page Start:
901
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. First‐Line Palliative HER2‐Targeted Therapy in HER2‐Positive Metastatic Breast Cancer Is Less Effective After Previous Adjuvant Trastuzumab‐Based Therapy. (August 2017)

Authors:
Rier, Hánah N.; Levin, Mark‐David; van Rosmalen, Joost; Bos, Monique M. E. M.; Drooger, Jan C.; de Jong, Paul; Portielje, Johanneke E. A.; Elsten, Elisabeth M. P.; Ten Tije, Albert‐Jan; Sleijfer, Stefan; Jager, Agnes
Journal:
Oncologist
Issue:
Volume 22:Number 8(2017)
Page Start:
901
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Human CXCR5+PD‐1+ CD8 T cells in healthy individuals and patients with hematologic malignancies. Issue 3 (23rd November 2020)

Authors:
Hofland, Tom; Martens, Anne W.J.; van Bruggen, Jaco A.C.; de Boer, Renate; Schetters, Sjoerd; Remmerswaal, Ester B.M.; Bemelman, Frederike J.; Levin, Mark‐David; Bins, Adriaan D.; Eldering, Eric; Kater, Arnon P.; Tonino, Sanne H.
Journal:
European journal of immunology
Issue:
Volume 51:Issue 3(2021)
Page Start:
703
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Spectrum of histiocytic neoplasms associated with diverse haematological malignancies bearing the same oncogenic mutation. (27th August 2020)

Authors:
Kemps, Paul G; Hebeda, Konnie M; Pals, Steven T; Verdijk, Robert M; Lam, King H; Bruggink, Annette H; de Lil, Heleen S; Ruiterkamp, Bart; de Heer, Koen; van Laar, Jan AM; Valk, Peter JM; Mutsaers, Pim; Levin, Mark‐David; Hogendoorn, Pancras CW; van Halteren, Astrid GS
Journal:
Journal of pathology
Issue:
Volume 7:Number 1(2021)
Page Start:
10
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Survival continues to increase in chronic lymphocytic leukaemia: a population‐based analysis among 20 468 patients diagnosed in the Netherlands between 1989 and 2016. (20th January 2020)

Authors:
van der Straten, Lina; Levin, Mark‐David; Visser, Otto; Posthuma, Eduardus F. M.; Doorduijn, Jeanette K.; Kater, Arnon P.; Dinmohamed, Avinash G.
Journal:
British journal of haematology
Issue:
Volume 189:Number 3(2020)
Page Start:
574
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗